Jure Sola
Analyst · Citibank. Your line is open
So let me be a little bit more specific. First of all, we've been talking about in the last year that I think we've been very fortunate that we are able to expand our customer base and bring some big new accounts. At the same time, we really won some good programs with our existing customers. And then we also have what I call whole programs that die, new programs that are coming up. So we have a lot of projects going on like that. When I was specifically talking about technical stuff that happened in one of the projects in our enterprise computing side, we had some issues on a customer side, that's been fixed, we started to ship. These are a bunch of minor things. If they didn't happen end of the quarter, it would give us really chance to deliver a little bit higher margins and few more dollars to the bottom line. If you look at the new programs, they are really across the board. If you look at the industrial side, that business we've grown. So, a lot of the good programs are really running on that side. Then we've got some smaller ones coming up. Communications side, we got programs that are transferring from old programs to new programs, we got some new transformation there, and it's moving pretty well. Few delayed programs; on the automotive side, we had a fair amount of programs that are ramping up and we expect those to be ramping up pretty nicely next six months. We thought they're going to ramp up three months ago, but we definitely have more confidence today, and we're going to see. So, really there's nothing major. It's one of those things, Jim, that we've seen it before. It depends on the customer side, on their internal growth and some of the technical issues, but nothing major. These are the programs that we are very familiar with, we work on all programs, so we are pretty confident. So, I think if you look at our guidance for this quarter, there's a lot of confidence there and we're hoping that if these things all move in the right direction, there is upside. Bob, anything else you want to add?